{"id":"https://openalex.org/W2080051183","doi":"https://doi.org/10.1371/journal.pone.0105638","title":"Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes","display_name":"Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes","alternate_titles":[],"publication_year":2014,"publication_date":"2014-08-28","ids":{"openalex":"https://openalex.org/W2080051183","doi":"https://doi.org/10.1371/journal.pone.0105638","mag":"2080051183","pmid":"https://pubmed.ncbi.nlm.nih.gov/25166023","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4148334"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0105638","doi":"https://doi.org/10.1371/journal.pone.0105638","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0105638","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0105638&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2080051183"],"child_works_count":13,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0105638&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113701102","display_name":"Sue Sha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sue Sha","raw_affiliation_strings":["Janssen Research & Development, LLC, Raritan, NJ, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Raritan, NJ, United States of America","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047898874","display_name":"Damayanthi Devineni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Damayanthi Devineni","raw_affiliation_strings":["Janssen Research & Development, LLC, Raritan, NJ, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Raritan, NJ, United States of America","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107881225","display_name":"Atalanta Ghosh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Atalanta Ghosh","raw_affiliation_strings":["Janssen Research & Development, LLC, Raritan, NJ, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Raritan, NJ, United States of America","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022867432","display_name":"David Polidori","orcid":"https://orcid.org/0000-0002-8427-5663","observed_orcids":["https://orcid.org/0000-0002-8427-5663"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Polidori","raw_affiliation_strings":["Janssen Research & Development, LLC, San Diego, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, San Diego, CA, United States of America","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044166679","display_name":"Marcus Hompesch","orcid":"https://orcid.org/0000-0001-5867-2131","observed_orcids":["https://orcid.org/0000-0001-5867-2131"]},"institutions":[{"id":"https://openalex.org/I4210134048","display_name":"Profil Institute for Clinical Research","ror":"https://ror.org/03f2dkv17","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210134048"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcus Hompesch","raw_affiliation_strings":["Profil Institute for Clinical Research, Chula Vista, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Profil Institute for Clinical Research, Chula Vista, CA, United States of America","institution_ids":["https://openalex.org/I4210134048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034644535","display_name":"Sabine Arnolds","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165534","display_name":"Profil Institute for Metabolic Research","ror":"https://ror.org/05krxy197","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210165534"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sabine Arnolds","raw_affiliation_strings":["Profil Institut f\u00fcr Stoffwechselforschung GmbH, Neuss, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Profil Institut f\u00fcr Stoffwechselforschung GmbH, Neuss, Germany","institution_ids":["https://openalex.org/I4210165534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084625858","display_name":"Linda Morrow","orcid":"https://orcid.org/0000-0003-3252-4477","observed_orcids":["https://orcid.org/0000-0003-3252-4477"]},"institutions":[{"id":"https://openalex.org/I4210134048","display_name":"Profil Institute for Clinical Research","ror":"https://ror.org/03f2dkv17","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210134048"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda Morrow","raw_affiliation_strings":["Profil Institute for Clinical Research, Chula Vista, CA, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Profil Institute for Clinical Research, Chula Vista, CA, United States of America","institution_ids":["https://openalex.org/I4210134048"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001945657","display_name":"Heike Spitzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165534","display_name":"Profil Institute for Metabolic Research","ror":"https://ror.org/05krxy197","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210165534"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Heike Spitzer","raw_affiliation_strings":["Profil Institut f\u00fcr Stoffwechselforschung GmbH, Neuss, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Profil Institut f\u00fcr Stoffwechselforschung GmbH, Neuss, Germany","institution_ids":["https://openalex.org/I4210165534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089781644","display_name":"Keith T. Demarest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith Demarest","raw_affiliation_strings":["Janssen Research & Development, LLC, Raritan, NJ, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Raritan, NJ, United States of America","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5081074918","display_name":"Paul Rothenberg","orcid":"https://orcid.org/0000-0001-9570-6927","observed_orcids":["https://orcid.org/0000-0001-9570-6927"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Rothenberg","raw_affiliation_strings":["Janssen Research & Development, LLC, Raritan, NJ, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Raritan, NJ, United States of America","institution_ids":["https://openalex.org/I4405282460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5113701102"],"corresponding_institution_ids":["https://openalex.org/I4405282460"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":7.7715,"has_fulltext":true,"cited_by_count":73,"citation_normalized_percentile":{"value":0.98137822,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"9","issue":"8","first_page":"e105638","last_page":"e105638"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9459999799728394},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.972000002861023},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9200000166893005},{"id":"https://openalex.org/keywords/urinary-glucose-excretion","display_name":"urinary glucose excretion","score":0.9629999995231628},{"id":"https://openalex.org/keywords/renal-glucose-threshold","display_name":"renal glucose threshold","score":0.9070000052452087},{"id":"https://openalex.org/keywords/plasma-glucose","display_name":"plasma glucose","score":0.7260000109672546},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.9419999718666077},{"id":"https://openalex.org/keywords/plasma-insulin","display_name":"plasma insulin","score":0.8450000286102295},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.8450000286102295},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8410000205039978},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7799999713897705},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.7319999933242798},{"id":"https://openalex.org/keywords/dose-dependence","display_name":"dose dependence","score":0.36899998784065247},{"id":"https://openalex.org/keywords/vaginal-candidiasis","display_name":"vaginal candidiasis","score":0.7870000004768372},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.6359999775886536},{"id":"https://openalex.org/keywords/urine-electrolyte-excretion","display_name":"urine electrolyte excretion","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.9951742887496948},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7251944541931152},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7093619108200073},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6318350434303284},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5259585380554199},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5201514363288879},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5151049494743347},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5145201086997986},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4133238196372986},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.36735183000564575},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2693547010421753},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068896","descriptor_name":"Canagliflozin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1371/journal.pone.0105638","doi":"https://doi.org/10.1371/journal.pone.0105638","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0105638","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0105638&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3113818","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4148334","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:25166023","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25166023","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4148334","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4148334/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:702046dc63b143b9a12cc8bdb0fc7c0f","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/702046dc63b143b9a12cc8bdb0fc7c0f","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 9, Iss 8, p e105638 (2014)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/1155381","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/_Pharmacodynamic_Effects_of_Canagliflozin_a_Sodium_Glucose_Co_Transporter_2_Inhibitor_from_a_Randomized_Study_in_Patients_with_Type_2_Diabetes_/1155381","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.945.3934","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.945.3934","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://journals.plos.org/plosone/article/asset?id%3D10.1371/journal.pone.0105638.PDF","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0105638","doi":"https://doi.org/10.1371/journal.pone.0105638","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0105638","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0105638&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306089","display_name":"American Diabetes Association","ror":"https://ror.org/04f6cgz95"},{"id":"https://openalex.org/F4320320870","display_name":"European Foundation for the Study of Diabetes","ror":"https://ror.org/05tgz4m05"},{"id":"https://openalex.org/F4320327566","display_name":"Mitsubishi Tanabe Pharma Corporation","ror":"https://ror.org/038ehsm73"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2080051183.pdf","grobid_xml":"https://content.openalex.org/works/W2080051183.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1488357183","https://openalex.org/W1606165384","https://openalex.org/W1972653282","https://openalex.org/W1974115114","https://openalex.org/W1982905493","https://openalex.org/W1987553321","https://openalex.org/W1997018189","https://openalex.org/W2001273251","https://openalex.org/W2038270027","https://openalex.org/W2055864845","https://openalex.org/W2068171948","https://openalex.org/W2070402425","https://openalex.org/W2074989651","https://openalex.org/W2077038286","https://openalex.org/W2084511068","https://openalex.org/W2095231407","https://openalex.org/W2105660444","https://openalex.org/W2109728760","https://openalex.org/W2120919346","https://openalex.org/W2120922908","https://openalex.org/W2130570549","https://openalex.org/W2135097670","https://openalex.org/W2152211669","https://openalex.org/W2152397610","https://openalex.org/W2154020052","https://openalex.org/W2155287847","https://openalex.org/W2158482469","https://openalex.org/W2162752164","https://openalex.org/W2167984652","https://openalex.org/W2168926920","https://openalex.org/W2169403426","https://openalex.org/W2170276146"],"related_works":["https://openalex.org/W1997018189","https://openalex.org/W1867144247","https://openalex.org/W1606165384","https://openalex.org/W2167984652","https://openalex.org/W2373302420","https://openalex.org/W1835375518","https://openalex.org/W2514433048","https://openalex.org/W2013892321","https://openalex.org/W2237021603","https://openalex.org/W2141800817"],"abstract_inverted_index":{"INTRODUCTION:":[0],"This":[1],"randomized,":[2],"double-blind,":[3],"placebo-controlled,":[4],"single":[5],"and":[6,14,69,97,109,124,144,185,196,225,279,288,291],"multiple":[7],"ascending-dose":[8],"study":[9,63,81],"evaluated":[10,131],"the":[11,66,162,245,250],"pharmacodynamic":[12],"effects":[13],"safety/tolerability":[15],"of":[16,235],"canagliflozin,":[17],"a":[18],"sodium":[19],"glucose":[20,100,104,117,189],"co-transporter":[21],"2":[22,28,39,62,91,199,300],"inhibitor,":[23],"in":[24,65,83,223,262,285,296],"patients":[25,297],"with":[26,154,158,166,173,204,208,244,298],"type":[27,299],"diabetes.":[29,301],"METHODS:":[30],"Patients":[31,43],"(N":[32],"=":[33],"116)":[34],"discontinued":[35],"their":[36],"antihyperglycemic":[37],"medications":[38],"weeks":[40],"before":[41],"randomization.":[42],"received":[44],"canagliflozin":[45,72,155,205],"30,":[46],"100,":[47],"200,":[48],"or":[49,54,59,71,77,270],"400":[50],"mg":[51,56,74],"once":[52,75],"daily":[53,76],"300":[55],"twice":[57],"daily,":[58],"placebo":[60,78],"at":[61,79],"centers":[64],"United":[67],"States":[68],"Germany,":[70],"30":[73],"1":[80,195,229],"center":[82],"Korea,":[84],"while":[85],"maintaining":[86],"an":[87,233],"isocaloric":[88],"diet":[89],"for":[90,116],"weeks.":[92,200],"On":[93],"Days":[94],"-1,":[95],"1,":[96],"16,":[98,255],"urinary":[99],"excretion":[101],"(UGE),":[102],"plasma":[103],"(PG),":[105],"fasting":[106],"PG":[107,210],"(FPG),":[108],"insulin":[110,202],"were":[111,191,206,218,257],"measured.":[112],"The":[113],"renal":[114,268],"threshold":[115],"(RTG)":[118],"was":[119,130,292],"calculated":[120],"from":[121],"UGE,":[122],"PG,":[123,286],"estimated":[125],"glomerular":[126],"filtration":[127],"rate.":[128],"Safety":[129],"based":[132],"on":[133,193],"adverse":[134],"event":[135],"(AE)":[136],"reports,":[137],"vital":[138],"signs,":[139],"electrocardiograms,":[140],"clinical":[141],"laboratory":[142,272],"tests,":[143],"physical":[145],"examinations.":[146],"RESULTS:":[147],"Canagliflozin":[148,169,181,212,238,276],"increased":[149,277],"UGE":[150,278],"dose-dependently":[151,170],"(\u223c80-120":[152],"g/day":[153],"\u2265100":[156],"mg),":[157],"increases":[159],"maintained":[160,197],"over":[161,198],"14-day":[163],"dosing":[164],"period":[165],"each":[167],"dose.":[168],"decreased":[171,280],"RTG,":[172,281],"maximal":[174],"reductions":[175,190,203,284],"to":[176,221,283],"\u223c4-5":[177],"mM":[178],"(72-90":[179],"mg/dL).":[180],"also":[182,213],"reduced":[183,214],"FPG":[184],"24-hour":[186],"mean":[187],"PG;":[188],"seen":[192],"Day":[194,254],"Plasma":[201],"consistent":[207,243],"observed":[209],"reductions.":[211],"body":[215,289],"weight.":[216],"AEs":[217],"transient,":[219],"mild":[220],"moderate":[222],"intensity,":[224],"balanced":[226],"across":[227],"groups;":[228],"canagliflozin-treated":[230],"female":[231],"reported":[232],"episode":[234],"vaginal":[236],"candidiasis.":[237],"did":[239],"not":[240],"cause":[241],"hypoglycemia,":[242],"RTG":[246],"values":[247],"remaining":[248],"above":[249],"hypoglycemia":[251],"threshold.":[252],"At":[253],"there":[256],"no":[258],"clinically":[259],"meaningful":[260],"changes":[261],"urine":[263,265],"volume,":[264],"electrolyte":[266],"excretion,":[267],"function,":[269],"routine":[271],"test":[273],"values.":[274],"CONCLUSIONS:":[275],"leading":[282],"insulin,":[287],"weight,":[290],"generally":[293],"well":[294],"tolerated":[295],"TRIAL":[302],"REGISTRATION:":[303],"ClinicalTrials.gov":[304],"NCT00963768.":[305]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2080051183","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
